TNFα inhibitor may be effective for severe COVID-19: learning from toxic epidermal necrolysis.

Increased inflammatory cytokines [such as tumor necrosis factor alpha (TNFα) and interleukin-6 (IL-6)] are observed in COVID-19 patients, especially in the severe group. The phenomenon of a cytokin...